507 related articles for article (PubMed ID: 2831244)
21. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency.
Costa-Barbosa FA; Tonetto-Fernandes VF; Carvalho VM; Nakamura OH; Moura V; Bachega TA; Vieira JG; Kater CE
Clin Endocrinol (Oxf); 2010 Dec; 73(6):700-6. PubMed ID: 20846292
[TBL] [Abstract][Full Text] [Related]
22. 21-Deoxycortisol and 17-hydroxyprogesterone responses to ACTH in hirsute women.
Milewicz A; Vecsei P; Gruszka S; Haack D; Bohdanowicz A; Medraś M; Wachtl J
Mater Med Pol; 1984; 16(2-4):86-90. PubMed ID: 6100121
[No Abstract] [Full Text] [Related]
23. Impaired mineralocorticoid hormone responses to adrenocorticotropin stimulation: additional characterization of heterozygosity for the 21-hydroxylase deficiency type of congenital adrenal hyperplasia.
Pardini DP; Kater CE; Vieira JG; Biglieri EG
J Clin Endocrinol Metab; 1983 Nov; 57(5):1061-6. PubMed ID: 6311859
[TBL] [Abstract][Full Text] [Related]
24. Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Lee PA; Rosenwaks Z; Urban MD; Migeon CJ; Bias WD
J Clin Endocrinol Metab; 1982 Nov; 55(5):866-71. PubMed ID: 6288754
[TBL] [Abstract][Full Text] [Related]
25. Development of plasma 21-deoxycortisol radioimmunoassay and application to the diagnosis of patients with 21-hydroxylase deficiency.
Milewicz A; Vecsei P; Korth-Schütz S; Haack D; Rösler A; Lichtwald K; Lewicka S; von Mittelstaedt G
J Steroid Biochem; 1984 Aug; 21(2):185-91. PubMed ID: 6090811
[TBL] [Abstract][Full Text] [Related]
26. Genotype of classic congenital adrenal hyperplasia and the 60-minute adrenocorticotropic hormone stimulation test.
Tsai WY; Lee JS; Hsiao PH; Hsieh RP
J Formos Med Assoc; 1995; 94(1-2):10-3. PubMed ID: 7613227
[TBL] [Abstract][Full Text] [Related]
27. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.
Ghizzoni L; Cappa M; Vottero A; Ubertini G; Carta D; Di Iorgi N; Gasco V; Marchesi M; Raggi V; Ibba A; Napoli F; Massimi A; Maghnie M; Loche S; Porzio O
Eur J Endocrinol; 2011 Aug; 165(2):307-14. PubMed ID: 21646284
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of 21-deoxycortisol as a marker for the detection of heterozygous carriers of 21-hydroxylase deficiency.
Milewicz A; Afelska A; Wasikowa R; Romer T
Endokrynol Pol; 1993; 44(2):187-93. PubMed ID: 8055790
[TBL] [Abstract][Full Text] [Related]
29. The application of a new highly-sensitive radioimmunoassay for plasma 21-deoxycortisol to the detection of steroid-21-hydroxylase deficiency.
Fiet J; Villette JM; Galons H; Boudou P; Burthier JM; Hardy N; Soliman H; Julien R; Vexiau P; Gourmelen M
Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():56-64. PubMed ID: 8154853
[TBL] [Abstract][Full Text] [Related]
30. Adrenal response to adrenocorticotropin hormone and HLA typing of subjects with different degrees of 21-hydroxylase deficiency.
Elias LL; Voltarelli JC; Moreira AC
Braz J Med Biol Res; 1993 Feb; 26(2):177-89. PubMed ID: 8257919
[TBL] [Abstract][Full Text] [Related]
31. Isolated precocious pubarche: an approach.
Balducci R; Boscherini B; Mangiantini A; Morellini M; Toscano V
J Clin Endocrinol Metab; 1994 Aug; 79(2):582-9. PubMed ID: 8045980
[TBL] [Abstract][Full Text] [Related]
32. Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone.
Turton DB; O'Brian JT; Shakir KM
J Endocrinol Invest; 1992 Dec; 15(11):789-96. PubMed ID: 1337905
[TBL] [Abstract][Full Text] [Related]
33. [Hormonal profile and HLA typing of adult subjects from 7 families with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency].
Bercovici JP; Tater D; Khoury S; Le Fur JM; Saleun JP; Nahoul K; Scholler R
Ann Endocrinol (Paris); 1982; 43(3):203-11. PubMed ID: 6984316
[TBL] [Abstract][Full Text] [Related]
34. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency.
Speiser PW; New MI
J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431
[TBL] [Abstract][Full Text] [Related]
35. Adrenocorticotropin stimulation test in congenital adrenal hyperplasia: comparison between standard and low dose test.
Panamonta O; Thinkhamrop B; Kirdpon W; Pudtawaro LO; Sungsahachart D
J Med Assoc Thai; 2003 Jul; 86(7):634-40. PubMed ID: 12948258
[TBL] [Abstract][Full Text] [Related]
36. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency.
Dewailly D; Vantyghem-Haudiquet MC; Sainsard C; Buvat J; Cappoen JP; Ardaens K; Racadot A; Lefebvre J; Fossati P
J Clin Endocrinol Metab; 1986 Aug; 63(2):418-23. PubMed ID: 3013919
[TBL] [Abstract][Full Text] [Related]
37. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Shibata Y
Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):819-39. PubMed ID: 1813324
[TBL] [Abstract][Full Text] [Related]
38. Changes of several adrenal delta 4-steroids measured by HPLC-UV spectrometry in neonatal patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Saisho S; Shimozawa K; Yata J
Horm Res; 1990; 33(1):27-34. PubMed ID: 2376395
[TBL] [Abstract][Full Text] [Related]
39. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
Granoff AB; Chasalow FI; Blethen SL
J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
[TBL] [Abstract][Full Text] [Related]
40. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
Otten BJ; Wellen JJ; Rijken JC; Stoelinga GB; Benraad TJ
J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
